Patents Examined by Elizabeth Slobodyonsky
  • Patent number: 5874273
    Abstract: The present invention relates to the discovery, identification and characterization of nucleotides that encode the G protein regulated phosphatidylinositol-3' kinase, a heterodimeric enzyme which produces the intracellular messenger phosphatidylinositol (3,4,5)-triphosphate in response to activation of trimeric G protein-linked receptors. This novel protein, comprised of a catalytic subunit, p120, and a regulatory subunit, p101, is found in cells of hematopoietic origin and is involved in immune system responses which cause inflammation. The presence of p101 subunit is largely responsible for the dramatic stimulation of kinase activity in the presence of activated trimeric G proteins.
    Type: Grant
    Filed: June 27, 1996
    Date of Patent: February 23, 1999
    Assignee: Onyx Pharmaceuticals
    Inventors: Len Stephens, Philip Thomas Hawkins
  • Patent number: 5859201
    Abstract: The present invention relates to the discovery, identification and characterization of nucleotides that encode the G protein regulated phosphatidylinositol-3' kinase, a heterodimeric enzyme which produces the intracellular messenger phosphatidylinositol (3,4,5)-triphosphate in response to activation of trimeric G protein-linked receptors. This novel protein, comprised of a catalytic subunit, p120, and a regulatory subunit, p101, is found in cells of hematopoietic origin and is involved in immune system responses which cause inflammation. The presence of p101 subunit is largely responsible for the dramatic stimulation of kinase activity in the presence of activated trimeric G proteins.
    Type: Grant
    Filed: November 18, 1997
    Date of Patent: January 12, 1999
    Assignee: Onyx Pharmaceuticals
    Inventors: Len Stephens, Phillip Thomas Hawkins